Find Grants — Mayo Clinic

1,900 - 1,919 out of 1,919 results

IGF::OT::IGF IGF CORE INFRASTRUCTURE SUPPORT
Limburg, P. J.
Project: Research project
IGF::OT::IGF LTRC RADIOLOGY CENTER - TASK ORDER 2 - 03/01/2017 - 02/28/2018 - CAN 17-8470204
Bartholmai, B. J.
National Heart, Lung, and Blood Institute
Project: Research project
Molecular Determinants of Human Pathogenic Bunyavirus Virulence and Evolution
Ebihara, H.
National Institute of Allergy and Infectious Diseases
Project: Research project
MUC1 Vaccine in Patients with Newly Diagnosed Advanced Adenomas
Limburg, P. J.
National Cancer Institute
Project: Research project
A PILOT STUDY OF MUC1 VACCINE IN CURRENT AND FORMER SMOKERS AT HIGH RISK FOR LUNG CANCER
Limburg, P. J.
Project: Research project
TAS::75 0872::TAS LUNG TISSUE RESEARCH CONSORTIUM CLINICAL CENTER
Limper, A. H.
Project: Research project
IGF::OT::IGF LTRC CLINICAL CENTER - TASK ORDER 001; SUBJECT CHARACTERIZATION AND TISSUE PROCUREMENT
Limper, A. H.
Project: Research project
CONTRACTOR: MAYO CLINIC; DUNNS: 006471700; PHASEI/II TRIAL OF A THERAPEUTIC DNA VACCINE FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION;HHSN261201200042I; TASK ORDER HHSN26100006; 09/09/2014 09/08/2016
Limburg, P. J.
Project: Research project
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
Limburg, P. J.
National Cancer Institute
Project: Research project
PILOT STUDY OF EGFR INHIBITION WITH ERLOTINIB IN CIRRHOSIS TO INHIBIT FIRBROGENESIS AND PREVENT HEPATOCELLULAR CARCINOMA HHSN261201200042I; TASK ORDER HHSN26
Limburg, P. J.
Project: Research project
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM
Limburg, P. J.
Project: Research project
IGF::OT::IGF RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MUC1 VACCINE IN PATIENTS WITH NEWLY DIAGNOSED ADVANCED ADENOMA
Limburg, P. J.
National Cancer Institute
Project: Research project
MUC1 Vaccine in Patients with Newly Diagnosed Advanced Adenomas
Limburg, P. J.
Project: Research project
IGF::OT::IGF PHASE I DOUBLE- BLIND, PLACEBO-CONTROLLED TRIAL OF 0.3MG LINACLOTIDE DELAYED-RELEASE (DR1) TO DEMONSTRATE COLORECTAL BIOACTIVITY IN HEALTHY VOLUNTEERS
Limburg, P. J.
Project: Research project
CORE INFRASTRUCTURE SUPPORT
Limburg, P. J.
Project: Research project
PHASEI/II TRIAL OF A THERAPEUTIC DNA VACCINE FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION;
Limburg, P. J.
Project: Research project
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
Limburg, P. J.
Project: Research project
PHASEI/II TRIAL OF A THERAPEUTIC DNA VACCINE FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION;
Limburg, P. J.
Project: Research project
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
Wheeler, A., Morris, A., Hubmayr, R. D., Hite, D., Deboisblanc, B., Brower, R., Macintyre, N., Wiedemann, H., Moss, M., Matthay, M., Steingrub, J., Hough, T., Sciurba, F., Limper, A. H., Sullivan, D., Bartholmai, B. J., Criner, G., Martinez, F., Woodruff, P., Kleerup, E., Martinez, Barr, G., Kanner, R., Bleecker, E., Couper, D., Cooper, A., Marathe, A., Tonascia, J., Motoki, C., Maxwell, T., Diaz, P., Schoenfeld, D., Casaburi, R., Albert, R., Fuhlbrigge, A., Matthay, M., Limper, A. H., Hoffman, E., Thompson, B., Au, D., Gay, S., Gaeke Torrence, C., Stibolt, T. & Tonascia, J.
National Heart, Lung, and Blood Institute
Project: Research project